# AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

NDC: 45802-066
Generic name: azelastine hydrochloride, fluticasone propionate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20210301

FDA application: ANDA208111

## Active ingredients

- AZELASTINE HYDROCHLORIDE: 137 ug/1
- FLUTICASONE PROPIONATE: 50 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-066"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-066
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=625ffdd0-8486-49af-8e77-6aa663be5ac7